DYADIC INTERNATIONAL INC Increase (Decrease) in Contract with Customer, Liability
DYADIC INTERNATIONAL INC (DYAI) reported Increase (Decrease) in Contract with Customer, Liability of -$166.68 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-12
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $453.60K, a 61.17% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$620.28K.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $393.71K, a 23.29% increase year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$496.39K, a 1643.51% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for fiscal 2025 was $897.04K, a 160.99% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for fiscal 2024 was $343.70K, a 23.52% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for fiscal 2023 was $449.37K.
- DYADIC INTERNATIONAL INC increase (decrease) in contract with customer, liability for fiscal 2022 was -$110.40K, a 492.46% decline from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $453.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$166.68K 10-Q · filed 2026-08-12 | $227.03K derived: sum of 3 quarters · filed 2026-08-12 | -$269.36K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$620.28K 10-Q · filed 2026-05-13 | -$226.57K derived: sum of 2 quarters · filed 2026-05-13 | -$722.96K derived: sum of 3 quarters · filed 2026-05-13 | $445.35K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $393.71K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$102.68K derived: sum of 2 quarters · filed 2026-03-25 | $1.07M derived: sum of 3 quarters · filed 2026-08-12 | $897.04K 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$496.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $671.92K derived: sum of 2 quarters · filed 2026-08-12 | $503.32K 10-Q · filed 2025-11-12 | $822.65K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $999.72K 10-Q · filed 2026-08-12 | $1.32M derived: sum of 3 quarters · filed 2026-08-12 | $1.35M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$168.60K 10-Q · filed 2026-05-13 | $150.73K derived: sum of 2 quarters · filed 2026-05-13 | $182.89K derived: sum of 3 quarters · filed 2026-05-13 | $131.20K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $319.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $351.49K derived: sum of 2 quarters · filed 2026-03-25 | $299.80K derived: sum of 3 quarters · filed 2026-03-25 | $343.70K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $32.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$19.54K derived: sum of 2 quarters · filed 2025-11-12 | $24.37K 10-Q · filed 2025-11-12 | $606.09K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$51.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$7.79K 10-Q · filed 2025-08-13 | $573.93K derived: sum of 3 quarters · filed 2025-08-13 | $473.32K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $43.91K 10-Q · filed 2025-05-14 | $625.63K derived: sum of 2 quarters · filed 2025-05-14 | $525.02K derived: sum of 3 quarters · filed 2025-05-14 | $468.81K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $581.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $481.11K derived: sum of 2 quarters · filed 2025-03-26 | $424.91K derived: sum of 3 quarters · filed 2025-03-26 | $449.37K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$100.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$156.82K derived: sum of 2 quarters · filed 2024-11-12 | -$132.35K 10-Q · filed 2024-11-12 | -$536.65K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$56.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$31.74K 10-Q · filed 2024-08-13 | -$436.04K derived: sum of 3 quarters · filed 2024-08-13 | -$892.33K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $24.46K 10-Q · filed 2024-05-14 | -$379.84K derived: sum of 2 quarters · filed 2024-05-14 | -$836.12K derived: sum of 3 quarters · filed 2024-05-14 | -$249.80K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$404.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$860.59K derived: sum of 2 quarters · filed 2024-03-28 | -$274.26K derived: sum of 3 quarters · filed 2024-03-28 | -$110.40K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$456.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $130.04K derived: sum of 2 quarters · filed 2023-11-08 | $293.90K 10-Q · filed 2023-11-08 | $282.36K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $586.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $750.18K 10-Q · filed 2023-08-09 | $738.65K derived: sum of 3 quarters · filed 2023-08-09 | $642.58K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $163.86K 10-Q · filed 2023-05-10 | $163.86M 10-Q · filed 2022-05-12 | $152.33K derived: sum of 2 quarters · filed 2023-05-10 | $56.26K derived: sum of 3 quarters · filed 2023-05-10 | -$719.04M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$11.53K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$107.60K derived: sum of 2 quarters · filed 2023-03-29 | -$719.20M derived: sum of 3 quarters · filed 2023-03-29 | $28.13K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$96.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$719.19M derived: sum of 2 quarters · filed 2022-11-10 | $39.66K 10-Q · filed 2022-11-10 | $8.82K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$719.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $135.73K 10-Q · filed 2022-08-10 | $104.89K derived: sum of 3 quarters · filed 2022-08-10 | $217.37K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $719.23M 10-Q · filed 2022-05-12 | $719.23K 10-Q · filed 2021-05-13 | $719.20M derived: sum of 2 quarters · filed 2022-05-12 | $719.31M derived: sum of 3 quarters · filed 2022-05-12 | $719.11M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$30.84K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $81.64K derived: sum of 2 quarters · filed 2022-03-29 | -$119.43K derived: sum of 3 quarters · filed 2022-03-29 | $44.37K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $112.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$88.59K derived: sum of 2 quarters · filed 2021-11-10 | $75.21K 10-Q · filed 2021-11-10 | $60.58K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$201.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$37.27K 10-Q · filed 2021-08-12 | -$51.90K derived: sum of 3 quarters · filed 2021-08-12 | -$49.20K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $163.80K 10-Q · filed 2021-05-13 | $149.17K derived: sum of 2 quarters · filed 2021-05-13 | $151.87K derived: sum of 3 quarters · filed 2021-05-13 | $219.42K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$14.63K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$11.93K derived: sum of 2 quarters · filed 2021-03-30 | $55.62K derived: sum of 3 quarters · filed 2021-03-30 | -$62.36K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $2.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $70.25K derived: sum of 2 quarters · filed 2020-11-12 | -$47.73K 10-Q · filed 2020-11-12 | $41.49K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $67.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$50.43K 10-Q · filed 2020-08-13 | $38.79K derived: sum of 3 quarters · filed 2020-08-13 | $48.76K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$117.98K 10-Q · filed 2020-05-14 | -$28.76K derived: sum of 2 quarters · filed 2020-05-14 | -$18.79K derived: sum of 3 quarters · filed 2020-05-14 | -$143.00K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $89.22K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $99.19K derived: sum of 2 quarters · filed 2020-03-30 | -$25.02K derived: sum of 3 quarters · filed 2020-03-30 | $141.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $9.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$114.24K derived: sum of 2 quarters · filed 2019-11-13 | $51.79K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$124.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $41.81K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $166.02K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$122.22K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |